Glenn Tong
Chief Executive Officer chez VGI HEALTH TECHNOLOGY LIMITED
Profil
Glenn Tong is currently the CEO, Managing Director & Executive Director at VGI Health Technology Ltd.
He was previously the Executive Chairman & Chief Executive Officer at Invictus BioPharma Ltd.
and the Chief Executive Officer & Managing Director at Gordagen Pharmaceuticals Pty Ltd.
Dr. Tong holds a doctorate degree from the University of Melbourne.
Postes actifs de Glenn Tong
Sociétés | Poste | Début |
---|---|---|
VGI HEALTH TECHNOLOGY LIMITED | Chief Executive Officer | 19/12/2019 |
Anciens postes connus de Glenn Tong
Sociétés | Poste | Fin |
---|---|---|
Gordagen Pharmaceuticals Pty Ltd. | Chief Executive Officer | - |
Invictus BioPharma Ltd.
Invictus BioPharma Ltd. Pharmaceuticals: MajorHealth Technology Invictus Biopharma Ltd. develops and commercializes novel dietary supplements and prescription medicines based on natural products. It offers delayed onset muscle soreness, muscle recovery, exercise endurance, non-alcoholic fatty liver disease, non-alcoholic steato hepatitis , pancreatic cancer, hyperlipidaemia, hypertension and diabetes. The company is headquartered in Melbourne, Australia. | Chief Executive Officer | - |
Formation de Glenn Tong
University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VGI HEALTH TECHNOLOGY LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Invictus BioPharma Ltd.
Invictus BioPharma Ltd. Pharmaceuticals: MajorHealth Technology Invictus Biopharma Ltd. develops and commercializes novel dietary supplements and prescription medicines based on natural products. It offers delayed onset muscle soreness, muscle recovery, exercise endurance, non-alcoholic fatty liver disease, non-alcoholic steato hepatitis , pancreatic cancer, hyperlipidaemia, hypertension and diabetes. The company is headquartered in Melbourne, Australia. | Health Technology |
Gordagen Pharmaceuticals Pty Ltd. |